Clarametyx 2022-06: Immunogenicity screening of three high-dose peptide immunogen concentrations without an adjuvant, administered subcutaneously naïve wild type mice

Project Details

StatusFinished
Effective start/end date6/06/22 → 5/06/23

Funding

  • Clarametyx Biosciences, Inc.: $10,202.00